Immune checkpoint receptors have become some of the most closely watched molecules in modern medicine, the molecular brakes ...
New research in Nature shows that gamma delta T cells rely on their adaptive T cell receptors in real time to mount rapid, ...
Delhi, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Global Gamma Delta T Cell Cancer Therapy Market Opportunity and Clinical Trials Insight 2030 Report Conclusions: Global Gamma Delta T Cell Therapy Clinical ...
The company’s lead autoimmune program, prula-cel, also known as ADI-001, is a CD20-targeted gamma delta 1 T-cell therapy. Schor said the asset was initially developed for non-Hodgkin lymphoma before ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results